PMG Research recognized for excellence in vaccine study execution

Winston-Salem, NC, April 19, 2017 – PMG Research, ICON’s integrated clinical research site network, today announced that it has been awarded Best Clinical Trial Site Network at the Vaccine Industry Excellence (ViE) Awards. PMG Research was presented with the award as a member of VaxCorps, which also includes Benchmark Research and Research Centers of America, at the World Vaccine Congress which took place in Washington last week.

The ViE Awards recognize the contributions of companies and individuals in the vaccine industry for their standards of excellence and achievements over the past 12 months. PMG Research and VaxCorps were selected based on criteria including:

  • Matching clinical development needs through a complete programmatic assessment
  • Supportive of multiple and diverse clinical phase and outcomes trials for vaccines
  • Methods of performance improvement or introduction of new services
  • Rapid enrollment across a vaccine ranges and outstanding study subject retention
  • Reaching of milestones and final / ongoing outcomes / trials

“The PMG Research team is proud to be honored for our standards of excellence in the execution of vaccine clinical trials.” stated Tonya Ward-Kiser, Senior Director of Operations at PMG Research. “We value the trust our sponsor partners put in PMG to provide a high-quality and patient-focused contribution to their vaccine development, and ultimately to improved health locally and globally.”

PMG Research spans 14 cities and 52 practice partners across North Carolina, South Carolina, Tennessee, Illinois and Iowa. With nearly 40 years of experience, PMG Research has conducted over 280 vaccine trials in indications including c. Difficile, e. coli, Ebola, herpes, HPV, influenza, MMR, meningococcal, pneumococcal, RSV, shingles, smallpox, staph aureus, TDAP, tetanus, and tuberculosis. To learn more about PMG Research’s vaccine capabilities, contact or visit

About PMG Research, Inc.

PMG Research, Inc, part of ICON Site & Patient Recruitment, is an integrated network of clinical research facilities with hub sites located in 14 cities in the southeastern and Midwestern United States. PMG has conducted 8,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. It has extensive experience conducting all phases of trials across a comprehensive list of conditions. PMG’s goal is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to clinical trial partners and stakeholders. To learn more, visit